EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news
« of 2 »






Recent news

» MPE Publishes 2021: Year in Review

» ASH 2021| over 50% of myeloma patients reach minimal residual disease negativity with Isatuximab in combination with RVd